Stockpolly
Search

Categories

Biotech

Companies that use biotechnology such as gene recombination, cell fusion, and nuclear transfer to develop new drugs and breeds.

−1.62% today·631 stocks·3 sub-categories

Stocks

By market cap · 631 stocks

  1. 1AbbVieABBVImmunology drugmaker behind Skyrizi, Rinvoq, and Botox$451.38B−1.04%
  2. 2MerckMRKMaker of Keytruda, vaccines, and animal medicines$366.18B−0.82%
  3. 3Novartis (ADR)NVSDeveloper of focused innovative medicines$292.35B−0.54%
  4. 4AstraZeneca (ADR)AZNOncology-led developer of specialty medicines$252.33B−1.12%
  5. 5AmgenAMGNMaker of Prolia, Repatha, and rare-disease medicines$233.38B−1.05%
  6. 6Thermo Fisher ScientificTMOScientific tools and outsourced biopharma services$231.22B−1.38%
  7. 7Gilead SciencesGILDDeveloper of HIV, liver-disease, and cancer medicines$180.87B−2.16%
  8. 8PfizerPFEDeveloper of Eliquis, Prevnar and cancer medicines$159.36B−0.21%
  9. 9Bristol-Myers SquibbBMYDeveloper of Eliquis, Opdivo and specialty medicines$136.00B−0.57%
  10. 10GSK (ADR)GSKDeveloper of Shingrix, Nucala, and Trelegy$101.82B+1.11%
  11. 11RegeneronREGNMaker of Dupixent, EYLEA HD, and Libtayo$81.82B−1.69%
  12. 12argenx (ADR)ARGXDeveloper of VYVGART autoimmune medicines$63.63B−3.35%
  13. 13ModernaMRNADeveloper of mRNA vaccines and therapeutics$54.75B−3.35%
  14. 14Revolution MedicinesRVMDDeveloper of RAS(ON) oncology candidates$44.19B−5.91%
  15. 15Agilent TechnologiesALaboratory instruments, diagnostics, and CrossLab services$43.45B−2.46%
  16. 16IQVIAIQVHealthcare intelligence and outsourced clinical research$43.08B−0.27%
  17. 17BeOne Medicines (ADR)ONCDeveloper of BRUKINSA and TEVIMBRA oncology medicines$39.19B−1.54%
  18. 18BiogenBIIBNeuroscience medicines across MS and rare disease$32.28B−1.36%
  19. 19Alnylam PharmaceuticalsALNYRNAi medicines built around gene-silencing delivery$31.73B+0.23%
  20. 20LabcorpLHClinical diagnostics and drug-development laboratory services$27.48B−0.38%
  21. 21Royalty PharmaRPRXBuyer and funder of drug royalties$26.97B−1.73%
  22. 22InsmedINSMTwo marketed pulmonary medicines and gene therapies$25.69B−2.38%
  23. 23BioNTech (ADR)BNTXComirnaty developer with an oncology pipeline$25.64B−8.36%
  24. 24IncyteINCYJakafi-led hematology, oncology, and immunology drug developer$25.21B−2.61%
  25. 25Roivant SciencesROIVVant-based developer of immunology medicines$25.07B−7.69%
  26. 26United TherapeuticsUTHRMaker of Tyvaso and investigational organ alternatives$21.88B−2.39%
  27. 27Genmab (ADR)GMABBuilder of antibody medicines and bispecific platforms$20.40B−2.58%
  28. 28ViatrisVTRSGlobal maker of established brands and generics$19.03B−3.26%
  29. 29MedpaceMEDPFull-service clinical trials for emerging biopharma sponsors$16.77B−1.81%
  30. 30Neurocrine BiosciencesNBIXDeveloper of INGREZZA and rare-disease medicines$15.49B−1.19%
  31. 31Jazz PharmaceuticalsJAZZSleep, epilepsy and oncology rare-disease medicines$15.36B−2.64%
  32. 32BridgeBio PharmaBBIOAttruby-led genetic disease drug developer$15.00B−2.67%
  33. 33Charles River LaboratoriesCRLResearch models and nonclinical drug-development testing$14.04B−1.69%
  34. 34ExelixisEXELBuilder of the cabozantinib oncology franchise$13.69B−1.52%
  35. 35Baxter InternationalBAXHospital infusion, connected-care, and injectable products$13.51B+0.77%
  36. 36ICONICLROperator of global drug and device trials$13.02B+0.11%
  37. 37BioMarinBMRNRare-disease therapies spanning enzymes and skeletal conditions$12.50B−0.98%
  38. 38Halozyme TherapeuticsHALOENHANZE platform for subcutaneous drug delivery$12.50B−1.47%
  39. 39Madrigal PharmaceuticalsMDGLMASH drug developer behind Rezdiffra$12.33B−1.81%
  40. 40Arrowhead PharmaceuticalsARWRDeveloper of targeted RNAi medicines$11.96B−4.15%
  41. 41Bio-TechneTECHMaker of life-science reagents and protein-analysis tools$11.33B−0.17%
  42. 42Summit TherapeuticsSMMTDeveloper of ivonescimab for solid tumors$10.95B−4.33%
  43. 43Krystal BiotechKRYSTopical VYJUVEK and redosable genetic medicine pipeline$10.36B−1.73%
  44. 44Axsome TherapeuticsAXSMCNS medicines for depression, agitation, sleepiness, and migraine$10.24B−3.49%
  45. 45Ionis PharmaceuticalsIONSAntisense medicines with owned and partnered launches$10.15B−2.23%
  46. 46RepligenRGENBioprocessing tools for biologics manufacturing$9.95B−3.20%
  47. 47Kymera TherapeuticsKYMROral protein degraders for immunological diseases$9.72B−1.79%
  48. 48Praxis Precision MedicinesPRAXPrecision neuroscience drug developer for tremor and epilepsy$9.61B−6.18%
  49. 49Protagonist TherapeuticsPTGXPeptide-drug developer behind ICOTYDE and rusfertide$9.28B−3.50%
  50. 50Crinetics PharmaceuticalsCRNXDeveloper of PALSONIFY and endocrine-disease therapies$8.99B+0.01%